
Solution Building: Merck Avoids One-Size-Fits-All Approach to AI and ML
Addressing the Goldman Sachs Healthcare C-Suite Unscripted Conference last year, Merck & Co. Chairman and CEO Robert A. Davis told investors the pharma giant was spending undisclosed “significant” capital toward automating processes, analyzing data, …